A common asthma inhaler drug descends from a compound once used against asthma in ancient India

A common asthma inhaler drug descends from a compound once used against asthma in ancient India
Image: Intellect (generated)

In short: Ipratropium bromide is an inhaled medicine that relaxes airway muscles to ease asthma and COPD. Its chemistry traces back to atropine, a compound found in the Datura stramonium plant, which was used for asthma in ancient India. Here is how an old plant remedy became a modern, carefully engineered drug.

Ipratropium bromide is an anticholinergic medication that goes by several brand names, most widely Atrovent. Its patent dates to 1966, and it received approval for medical use in 1974. Today it is listed by the World Health Organization among the medicines regarded as most important for a health system, and generic versions exist. In 2023 it ranked 268th among commonly prescribed medications in the United States, with well over 900,000 prescriptions filled.

Chemically, the drug is a quaternary ammonium compound. It is made by treating atropine with isopropyl bromide, which is where its name comes from. The source notes that Datura stramonium contains related chemistry and was used in ancient India for asthma. The drug blocks muscarinic acetylcholine receptors without favouring any subtype. This reduces the signalling that tightens airway smooth muscle, so the bronchi open and mucus secretion falls. Because the molecule is a quaternary amine, it does not readily enter the bloodstream or cross into the brain, which limits whole-body and central side effects.

Its effects depend on the route of use. Inhaled by inhaler or nebulizer, it opens the medium and large airways and is used for COPD and asthma. The effect typically begins within 15 to 30 minutes and lasts three to five hours. Taken as a nasal spray, it reduces a runny nose from allergic or nonallergic rhinitis and the common cold, but it does not relieve congestion. It should never replace salbutamol as a rescue medication. Inhaled side effects are usually mild, with dry mouth and cough the most noted, while urinary retention is a rarer concern, particularly in people with prostate enlargement.

Research continues beyond its established uses. A study using an artificial intelligence drug-screening platform identified ipratropium bromide as a candidate for severe COVID-19. In a hamster model, the treated groups showed lower markers of clotting than the untreated group. The authors describe this as early animal research, which does not establish a treatment for people. Separately, researchers have developed sensors based on cucurbituril that measure the drug in inhalers and human plasma, a step toward better monitoring in cases of accidental ingestion.

Opens the Intellect+ feed with this card first. Swipe up for the next one.

Sources

To cite this card, link to https://intellectplus.co.uk/app/health-ipratropium-bromide.

How we source, check and correct cards: Editorial standards.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

Finding something worth knowing…